These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6107120

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG.
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract] [Full Text] [Related]

  • 4. [Field trial with a new betablocker (Solgol)].
    Piergies A, Schimert G.
    MMW Munch Med Wochenschr; 1980 Oct 17; 122(42):1473-6. PubMed ID: 6110182
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P, Bellocci F, Santarelli P, Iannarelli M.
    Clin Ter; 1986 Jan 15; 116(1):19-24. PubMed ID: 2870837
    [No Abstract] [Full Text] [Related]

  • 6. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr 18; 22(8):33-4. PubMed ID: 6102734
    [No Abstract] [Full Text] [Related]

  • 7. [Our experience on the clinical use of nadolol].
    Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G.
    Minerva Cardioangiol; 1985 Oct 18; 33(10):629-34. PubMed ID: 2867492
    [No Abstract] [Full Text] [Related]

  • 8. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS, Fand RS.
    Ir Med J; 1979 Dec 18; 72(12):522-9. PubMed ID: 44273
    [No Abstract] [Full Text] [Related]

  • 9. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA.
    J Fam Pract; 1980 Aug 18; 11(2):199-205. PubMed ID: 6106039
    [Abstract] [Full Text] [Related]

  • 10. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
    Del Re ML, Ricci A, Abate G.
    Clin Ter; 1986 Mar 15; 116(5):385-90. PubMed ID: 2871962
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of the hypotensive effects of nadolol].
    Hanzlik J, Sodolski W, Stelmasiak T, Wolański I.
    Kardiol Pol; 1982 Mar 15; 25(2):101-6. PubMed ID: 6125620
    [No Abstract] [Full Text] [Related]

  • 13. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL.
    Ugeskr Laeger; 1975 Sep 22; 137(39):2274-6. PubMed ID: 241148
    [No Abstract] [Full Text] [Related]

  • 14. [Combined treatment of arterial hypertension. Comparison of a beta-blocker plus a saluretic combination with beta-blocker].
    Rodatz KW, Hörder MH.
    MMW Munch Med Wochenschr; 1983 Feb 18; 125(7):136-8. PubMed ID: 6133217
    [No Abstract] [Full Text] [Related]

  • 15. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A.
    Ther Hung; 1986 Feb 18; 34(3):171-4. PubMed ID: 2894722
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE, Khvoĭnitskiĭ VA.
    Sov Med; 1984 Feb 18; (5):87-9. PubMed ID: 6147019
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of nadolol in coronary disease].
    Krotkiewski A, Zatorski A, Jarecki M, Ruszkowski J, Szelemetko J.
    Pol Tyg Lek; 1980 Jun 02; 35(22):833-6. PubMed ID: 6106925
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.